| |
Our Life Science practice group provides
advice to early stage biotech companies as well as mature drug
developers. We have advised Life Science clients on
in-licensing and out-licensing transactions, public, private and
PIPE financing transactions, innovative joint ventures,
co-development and collaboration arrangements and mergers &
acquisitions.
The
practical advice we provide in Life Science transactions allows
our clients to negotiate and achieve superior results and
realize their goals in today’s ever changing biotech and drug
development environment. As our representative transactions in
Life Science demonstrate, we are comfortable providing advice in a complex, milestone-driven in-licensing transaction for an
early stage biotech concern as well as in the sale of a later stage
generic drug manufacturer to a public acquirer.
Strong
corporate fundamentals combined with experience in innovative
transactions make Reitler Kailas & Rosenblatt a wise choice for
counsel in Life Science transactions. |
|
